D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
PUT
Suncor Energy
SU
$84.5B
| $103M | 0.06% |
1,555,000
-190,000
| -11% | -$10.5M |
2022 Q2
15 quarters
|
|
352
Avantor
AVTR
$10.6B
| $103M | 0.06% |
13,110,674
+6,894,751
| +111% | +$67.8M |
2021 Q1
20 quarters
|
|
353
Axsome Therapeutics
AXSM
$8.82B
| $102M | 0.06% |
603,465
+54,352
| +10% | +$9.39M |
2023 Q4
9 quarters
|
|
354
Deere & Co
DE
$167B
| $102M | 0.06% |
180,665
-4,611
| -2% | -$2.6M |
2025 Q3
2 quarters
|
|
355
CALL
Salesforce
CRM
$189B
| $101M | 0.06% |
541,400
+151,800
| +39% | +$31.5M |
2025 Q2
3 quarters
|
|
356
Baytex Energy
BTE
$3.36B
| $101M | 0.06% |
22,571,938
+9,558,534
| +73% | +$35.3M |
2024 Q4
5 quarters
|
|
357
PUT
Citigroup
C
$217B
| $101M | 0.06% |
887,800
-822,300
| -48% | -$93.6M |
2013 Q2
51 quarters
|
|
358
CALL
Adobe
ADBE
$94.3B
| $100M | 0.06% |
412,000
+48,200
| +13% | +$13.4M |
2025 Q2
3 quarters
|
|
359
CALL
SoFi Technologies
SOFI
$20.4B
| $100M | 0.06% |
6,305,000
-1,792,900
| -22% | -$37.8M |
2022 Q1
16 quarters
|
|
360
Revolution Medicines
RVMD
$40.7B
| $99.4M | 0.06% |
1,022,298
-591,432
| -37% | -$59.7M |
2025 Q2
3 quarters
|
|
361
CALL
Uber
UBER
$146B
| $99.4M | 0.06% |
1,382,000
-329,800
| -19% | -$25.4M |
2020 Q1
24 quarters
|
|
362
PUT
Arm
ARM
$284B
| $99.2M | 0.06% |
656,000
-563,100
| -46% | -$68.3M |
2024 Q1
8 quarters
|
|
363
Sunrun
RUN
$1.84B
| $98.5M | 0.06% |
7,261,297
-2,645,151
| -27% | -$44M |
2025 Q2
3 quarters
|
|
364
Natera
NTRA
$57.8B
| $98.3M | 0.06% |
491,336
-62,271
| -11% | -$13.4M |
2020 Q1
24 quarters
|
|
365
PUT
Circle Internet Group
CRCL
$21.5B
| $98M | 0.06% |
1,026,800
+836,800
| +440% | +$70.9M |
2025 Q3
2 quarters
|
|
366
PUT
ServiceNow
NOW
$146B
| $97.7M | 0.06% |
934,800
+96,800
| +12% | +$11.4M |
2017 Q4
33 quarters
|
|
367
Enviri
NVRI
$557M
| $97.7M | 0.06% |
4,980,660
+583,962
| +13% | +$10.8M |
2015 Q1
44 quarters
|
|
368
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
| $97.5M | 0.06% |
902,693
+777,383
| +620% | +$90.8M |
2025 Q4
1 quarter
|
|
369
Ralph Lauren
RL
$22.1B
| $97.2M | 0.06% |
282,540
+126,310
| +81% | +$44.9M |
2022 Q4
13 quarters
|
|
370
CALL
Altria Group
MO
$120B
| $96.9M | 0.06% |
1,468,100
-101,100
| -6% | -$6.5M |
2021 Q2
19 quarters
|
|
371
Coupang
CPNG
$28.4B
| $96.7M | 0.06% |
5,122,598
-4,153,935
| -45% | -$81.3M |
2022 Q4
13 quarters
|
|
372
CALL
Chevron
CVX
$416B
| $96.6M | 0.06% |
466,900
-710,600
| -60% | -$130M |
2013 Q2
51 quarters
|
|
373
CALL
Pinduoduo
PDD
$116B
| $96.5M | 0.06% |
944,000
-1,263,000
| -57% | -$133M |
2019 Q3
26 quarters
|
|
374
ImmunityBio
IBRX
$11.1B
| $96.4M | 0.06% |
+12,571,597
| New | +$86.1M |
2026 Q1
0 quarters
|
|
375
Humana
HUM
$51.9B
| $96.3M | 0.06% |
555,207
+101,735
| +22% | +$20.9M |
2013 Q2
51 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.